Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.24.1.u1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
 [1]
Current Assets:    
Cash and cash equivalents $ 29,310 $ 30,014
Restricted cash 12,762 15,466
Accounts receivable (net of allowance for credit losses of $58 and $85, respectively) 58,081 58,729
Inventories 42,610 52,611
Derivative instruments 52 2,412
Other current assets 8,028 9,538
Total current assets 150,843 168,770
Property and equipment, net 248,901 248,748
Other Assets:    
Right of use operating lease assets, net 21,506 22,597
Intangible assets, net 8,351 8,498
Other assets 5,034 5,628
Total other assets 34,891 36,723
Total Assets 434,635 454,241
Current Liabilities:    
Accounts payable 18,508 20,752
Accrued liabilities 18,166 20,205
Current portion – operating leases 4,486 4,333
Derivative instruments 8,299 13,849
Other current liabilities 5,595 6,149
Total current liabilities 55,054 65,288
Long-term debt 84,069 82,097
Operating leases, net of current portion 17,895 19,029
Other liabilities 8,958 8,270
Total Liabilities 165,976 174,684
Commitments and Contingencies
Stockholders’ Equity:    
Preferred stock, value 1 1
Common stock, value 77 76
Additional paid-in capital 1,042,053 1,040,912
Accumulated other comprehensive income 2,481 2,481
Accumulated deficit (775,953) (763,913)
Total stockholders’ equity 268,659 279,557
Total Liabilities and Stockholders’ Equity 434,635 454,241
Non-voting common stock    
Stockholders’ Equity:    
Common stock, value
[1] Amounts derived from the audited financial statements for the year ended December 31, 2023.